Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-20

Clinical Trial Update: Effect of Sea Weed (Ecklonia Cava Extract) on Blood Glucose and Insulin Level on Pre-diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of Ecklonia cava extract from seaweed on blood glucose and insulin levels in prediabetic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sea Weed (Ecklonia Cava Extract)

Snippet

Sponsor: King Saud University | Conditions: PreDiabetes | Phase 4 | Status: UNKNOWN